Anthony Bihl

Président chez SONENDO, INC. Fortune : 646 $ au 31/05/2026

Profil

Anthony P.
Bihl currently works at Sonendo, Inc., as Chairman and The Arthritis Foundation, as Director.
Mr. Bihl also formerly worked at Bayer Healthcare LLC, as CEO- Siemens Medical Solutions Diagnostics in 2007, Siemens Medical Solutions Diagnostics, Inc., as Chief Executive Officer in 2007, Bioventus LLC, as Chief Executive Officer & Director from 2015 to 2020, Bioventus, Inc., as Chief Executive Officer & Director from 2016 to 2020, Bioventus, Inc., as President, Chief Executive Officer & Director from 2023 to 2024, Nuvectra Corp., as Chairman from 2019 to 2020, Meridian Bioscience, Inc., as Independent Director from 2020 to 2023, Integer Holdings Corp., as Independent Director from 2011 to 2016, SeraCare Life Sciences, Inc., as Director, Flowonix Medical, Inc., as Director from 2020 to 2022, Adnavance Technologies, Inc., as Director, Greatbatch, Inc., as Director from 2011 to 2016, Spectral Medical, Inc., as Director in 2024, Endo Health Solutions, Inc., as President, Astora Women's Health, Inc., as Group President from 2011 to 2012, Bayer Diagnostics Corp., as Vice President-Finance & Controlling in 2002, and American Medical Systems, Inc., as President from 2011 to 2012.
Mr. Bihl received his undergraduate degree from The Pennsylvania State University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
SONENDO INC 0,46 %	19/03/2025	1 959 ( 0,46 % )	646 $	31/05/2026

Postes actifs de Anthony Bihl

Sociétés	Poste	Début
SONENDO, INC.	Président	-
The Arthritis Foundation	Directeur/Membre du Conseil	-

Anciens postes connus de Anthony Bihl

Sociétés	Poste	Fin
SPECTRAL MEDICAL INC.	Président	02/04/2024
BIOVENTUS INC.	Directeur Général	10/01/2024
MERIDIAN BIOSCIENCE, INC.	Directeur/Membre du Conseil	31/01/2023
Flowonix Medical, Inc.	Directeur/Membre du Conseil	01/03/2022
NUVECTRA CORPORATION	Président	01/05/2020